Immunotherapy Using 41BB Selected Tumor Infiltrating Lymphocytes for Patients With Metastatic Melanoma
Clinical trial NCT02111863 · TERMINATED
Trial details
- NCT number
- NCT02111863
- Sponsor
- National Cancer Institute (NCI)
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-21
- Primary completion
- 2016-07-21
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.